• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Pfizer Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 434.0
  • ISIN : INE182A01018
5,054.50 -140 (-2.70%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    5,025.00

  • Today’s High

    5,246.00

  • Open

    5,246.00

  • Perv Close

    5,194.50

  • 52W Low

    3,701.00

  • 52W High

    6,451.15

Key Indicators

  • P/E(TTM)

    36.06

  • Mar.Cap (₹Cr.)

    23,123.19

  • Div & Yield %

    3.27

  • Book Value(₹)

    921.88

  • Debt-Equity Ratio

    -2.70

  • AGM Date

    01-Aug-2025

  • EPS

    140.08

  • P/E Ratio

    36.06

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    23,123.19

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    45.75

  • BV (₹)

    921.90

  • Sales( ₹ in Cr.)

    2,281.35

  • NP (in Cr.)

    640.84

  • NP Var(%)

    17.0

  • Div%

    1650.0

  • CPS (₹)

    153.40

  • EPS (₹)

    140.10

  • Traded Value (₹ in Lakhs)

    23,105.81

  • 52 Week High

    6,451.15

  • 52 Week Low

    3,701.00

  • Price BSE

    5051.0

  • Price NSE

    5,055.00

  • Market Capital( in Cr.)

    23,105.81

  • P/C Ratio

    32.90

  • P/E Ratio

    36.10

  • Price Vs.BV

    140.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 2,281.35 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,281.35 2,193.17 2,424.76 2,610.99 2,238.55 2,151.65
Other Income 345.06 188.46 134.05 62.65 81.12 184.02
Stock Adjustments -25.36 11.82 -56.48 72.90 -14.35 36.62
Total Income 2,601.05 2,393.45 2,502.33 2,746.54 2,305.32 2,372.29
EXPENDITURE :            
Raw Materials 785.09 804.39 817.19 1,020.93 783.39 829.02
Power and Fuel Cost 3.48 3.98 6.51 5.67 5.79 11.04
Employee Cost 371.33 347.80 331.68 403.67 361.06 364.51
Other Manufacturing Expenses 50.54 51.17 51.63 59.81 60.26 54.26
Selling and Administration Expenses 260.05 317.96 298.03 310.77 268.67 319.66
Miscellaneous Expenses 45.18 44.37 54.29 47.10 32.63 37.06
Employee Benefit Expenses 371.33 347.80 331.68 403.67 361.06 364.51
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,515.67 1,569.67 1,559.33 1,847.95 1,511.80 1,615.55
Operating Profit 1,085.38 823.78 943.00 898.59 793.52 756.74
Interest 8.50 15.43 13.48 10.70 15.39 11.01
Gross Profit 1,076.88 808.35 929.52 887.89 778.13 745.73
Depreciation 60.79 62.28 105.51 115.00 109.41 103.24
Profit Before Tax 1,016.09 746.07 824.01 772.89 668.72 642.49
Current Tax 264.10 158.63 251.99 196.26 183.63 133.20
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -15.61 36.11 -51.91 -35.93 -12.52 0.16
Reported Net Profit 767.60 551.33 623.93 612.56 497.61 509.13
Extraordinary Items 126.76 3.62 22.95 1.13 0.06 -0.80
Adjusted Net Profit 640.84 547.71 600.98 611.43 497.55 509.93
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,828.39 1,460.05 1,133.47 681.03 1,693.08 1,308.04
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 160.13 182.99 297.35 160.12 1,509.66 124.09
P & L Balance carried down 2,435.86 1,828.39 1,460.05 1,133.47 681.03 1,693.08
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,650.00 350.00 700.00 350.00 350.00 3,300.00
Dividend Per Share(Rs) 165.00 35.00 70.00 35.00 35.00 330.00
Earnings Per Share-Unit Curr 167.78 120.51 136.38 133.89 108.77 111.29
Earnings Per Share(Adj)-Unit Curr 167.78 120.51 136.38 133.89 108.77 111.29
Book Value 921.84 785.91 701.05 626.10 523.07 742.18
Book Value(Adj)-Unit Curr 921.84 785.91 701.05 626.10 523.07 742.18

Shareholding Pattern

  • Promoter Group

    63.92%

  • Public Share Holding

    36.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 29,243,042 63.92 29,243,042 7
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 29,243,042 63.92 29,243,042 7
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 188 0.00 125 4
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,972 0.02 5,973 18
Foreign Bank 186 0.00 0 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,094,232 2.39 1,094,221 74
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,495,183 5.45 2,495,183 11
Mutual Funds / UTI 5,352,030 11.70 5,351,530 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 29,071 0.06 29,071 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,977,862 19.62 8,976,103 139
2] Non Institution
Bodies Corporate 1,216,642 2.66 1,212,060 602
Clearing Members 12,498 0.03 12,496 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 238,004 0.52 237,126 2,910
Foreign Non Institution Other 310 0.00 0 2
Hindu Undivided Families 134,983 0.30 134,983 2,041
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 212,621 0.46 212,621 12
Individuals holding nominal share capital up to Rs. 1 lakh 5,288,483 11.56 4,999,381 97,489
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,140 0.00 2,105 9
Others 421,147 0.92 421,147 2
Sub Total 7,526,828 16.45 7,231,919 103,076
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 45,747,732 100.00 45,451,064 103,222

Company Background

Pfizer LtdPharmaceuticals - Multinational

  • Pfizer Ltd
  • BSE Code : 434.0
  • ISIN : INE182A01018

  • Incorporation Year

    1950

  • Registered Office

    The Capital 1802/1901 Plot-C70
    G Bl Bandra Kurla Cpx Bandra-E, Mumbai,
    Maharashtra-400051

  • Telephone

    91-22-66932000

  • FAX

    91-22-26540274

  • Chairman

    Pradip P Shah

  • Managing Director

    Meenakshi Nevatia

  • Company Secretary

    Prajeet Nair

  • Auditor

    B S R & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Pfizer Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Pfizer 5,050.70 2,453.60 2,281.35 30.10 21.06
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10